Stage IIIA Hilar Cholangiocarcinoma
2 clinical trials · Condition
◉ Watch Stage IIIA Hilar Cholangiocarcinoma
| Record | Firm | Date |
|---|---|---|
| Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma (NCT02856568) | Mayo Clinic | 2017-05-01 |
| ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer (NCT01825603) | University of Nebraska | 2013-04-09 |
Track Stage IIIA Hilar Cholangiocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.